Algorithm for the medical management of stable angina. High-risk candidates for revascularization on prognostic grounds alone should be identified and referred appropriately. ^*Relative contraindications to beta-blockade include asthma, symptomatic peripheral vascular disease, and first degree heart block. ^††Avoid short-acting dihydropyridine formulations when not combined with beta-blocker. Evidence for prognosis refers to evidence of reduction in CV death or CV death/MI. Evidence for symptoms includes reduction in the need for revascularization and hospitalization for chest pain.